Evidence map›Paper›PMID 26971867›Full record

ArticleCell chemical biology2016

"Death is my Heir"--Ferroptosis Connects Cancer Pharmacogenomics and Ischemia-Reperfusion Injury.

Wulf Tonnus, Andreas Linkermann

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. In defence of ferroptosis.Signal transduction and targeted therapy · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The role of regulated necrosis in endocrine diseases.Nature reviews. Endocrinology · 2021
    Review
  11. Review
  12. Review
  13. Review
  14. Targeting ferroptosis in breast cancer.Biomarker research · 2020
    Review
  15. Ferroptosis: regulated cell death.Arhiv za higijenu rada i toksikologiju · 2020
    Review
  16. Review
  17. Roles of TRAFs in Ischemia-Reperfusion Injury.Frontiers in cell and developmental biology · 2020
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Wulf TonnusClinic for Nephrology and Hypertension, Christian-Albrechts-University, Kiel 24105, Germany.
Andreas LinkermannClinic for Nephrology and Hypertension, Christian-Albrechts-University, Kiel 24105, Germany. Electronic address: andreas.linkermann@uksh.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although they are key to precision medicine, pharmacokinetics and pharmacogenomics are currently plagued with inconsistent results. In this issue of Cell Chemical Biology, Shimada et al. (2016) use cell line selectivity and appropriate filters to improve the consistency and to identify biomarkers for the selectivity of lethal compounds. These insights may be useful for our understanding of how necrosis and ischemic injury are regulated.

Indexed as

PharmacogeneticsReperfusion InjuryApoptosisCell DeathHumansIschemiaIschemic PreconditioningIschemic Preconditioning, MyocardialMyocardial IschemiaMyocardial Reperfusion InjuryNecrosisNeoplasmsTime FactorsTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.